X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13366) 13366
Book Chapter (19) 19
Magazine Article (11) 11
Dissertation (7) 7
Trade Publication Article (2) 2
Book / eBook (1) 1
Book Review (1) 1
Newsletter (1) 1
Newspaper Article (1) 1
Publication (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
bevacizumab (11394) 11394
humans (10752) 10752
female (6813) 6813
male (5816) 5816
oncology (5422) 5422
middle aged (5133) 5133
aged (4885) 4885
adult (3465) 3465
chemotherapy (3411) 3411
treatment outcome (3380) 3380
ophthalmology (3291) 3291
antineoplastic combined chemotherapy protocols - therapeutic use (3146) 3146
cancer (3071) 3071
angiogenesis inhibitors - administration & dosage (3013) 3013
antibodies, monoclonal, humanized (2735) 2735
endothelial growth-factor (2594) 2594
vascular endothelial growth factor (2564) 2564
vascular endothelial growth factor a - antagonists & inhibitors (2464) 2464
angiogenesis inhibitors - therapeutic use (2339) 2339
aged, 80 and over (2156) 2156
angiogenesis (2136) 2136
antibodies, monoclonal - administration & dosage (2108) 2108
antibodies, monoclonal, humanized - administration & dosage (2057) 2057
care and treatment (2015) 2015
intravitreal injections (1856) 1856
retrospective studies (1790) 1790
therapy (1770) 1770
ranibizumab (1716) 1716
animals (1619) 1619
metastasis (1593) 1593
medicine & public health (1519) 1519
bevacizumab - administration & dosage (1491) 1491
follow-up studies (1408) 1408
colorectal neoplasms - drug therapy (1405) 1405
macular degeneration (1401) 1401
research (1388) 1388
colorectal cancer (1379) 1379
disease-free survival (1344) 1344
survival (1311) 1311
drug therapy (1298) 1298
pharmacology & pharmacy (1274) 1274
antineoplastic combined chemotherapy protocols - adverse effects (1247) 1247
trial (1208) 1208
antibodies, monoclonal - therapeutic use (1203) 1203
patients (1153) 1153
angiogenesis inhibitors - adverse effects (1151) 1151
angiogenesis inhibitors (1136) 1136
vegf (1136) 1136
clinical trials (1119) 1119
analysis (1106) 1106
colorectal neoplasms - pathology (1081) 1081
tomography, optical coherence (1074) 1074
tumors (1059) 1059
surgery (1052) 1052
prognosis (1050) 1050
combination (1030) 1030
antineoplastic combined chemotherapy protocols - administration & dosage (1020) 1020
fluorouracil - administration & dosage (1014) 1014
antibodies, monoclonal, humanized - therapeutic use (1002) 1002
antineoplastic agents - therapeutic use (992) 992
prospective studies (980) 980
antineoplastic agents (950) 950
fluorouracil (920) 920
lung neoplasms - drug therapy (917) 917
hematology, oncology and palliative medicine (911) 911
antimitotic agents (909) 909
eye diseases (906) 906
cancer therapies (899) 899
oxaliplatin (884) 884
visual acuity (881) 881
fluorescein angiography (876) 876
paclitaxel (874) 874
neoplasm staging (858) 858
neoplasm metastasis (843) 843
antibodies, monoclonal - adverse effects (805) 805
health aspects (796) 796
irinotecan (791) 791
avastin (787) 787
1st-line treatment (785) 785
camptothecin - analogs & derivatives (777) 777
leucovorin (765) 765
expression (755) 755
organoplatinum compounds - administration & dosage (747) 747
neovascularization (741) 741
efficacy (737) 737
antibodies, monoclonal, humanized - adverse effects (734) 734
genetic structures (731) 731
studies (726) 726
mice (725) 725
survival rate (718) 718
injection (716) 716
cetuximab (711) 711
carcinoma, non-small-cell lung - drug therapy (703) 703
combined modality therapy (703) 703
intravitreal bevacizumab (702) 702
time factors (700) 700
drug administration schedule (697) 697
phase-ii trial (688) 688
injections (687) 687
abridged index medicus (661) 661
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12787) 12787
Japanese (264) 264
German (174) 174
French (125) 125
Spanish (48) 48
Chinese (28) 28
Polish (16) 16
Russian (15) 15
Hungarian (14) 14
Czech (9) 9
Romanian (9) 9
Italian (8) 8
Korean (8) 8
Portuguese (4) 4
Finnish (3) 3
Swedish (3) 3
Arabic (1) 1
Hebrew (1) 1
Icelandic (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Japanese Journal of Clinical Oncology, ISSN 0368-2811, 05/2015, Volume 45, Issue 5, pp. 408 - 410
Several 'lines of therapy' that utilize cytotoxic agents and are driven by platinum-free intervals are the current standard of care for patients with recurrent... 
Chemo-gynecology | Molecular Dx | Gynecol-med | PEGYLATED LIPOSOMAL DOXORUBICIN | CARBOPLATIN | gynecol-med | BEVACIZUMAB | molecular Dx | COMBINATION | CHEMOTHERAPY | PACLITAXEL | PHASE-III TRIAL | THERAPY | ONCOLOGY | DOUBLE-BLIND | PROGRESSION | chemo-gynecology | Piperazines - administration & dosage | Humans | Neoplasm Recurrence, Local - drug therapy | Antineoplastic Agents - therapeutic use | Folic Acid - administration & dosage | TOR Serine-Threonine Kinases - antagonists & inhibitors | Antibodies, Monoclonal, Humanized - administration & dosage | Vinca Alkaloids - administration & dosage | Benzimidazoles - administration & dosage | Doxorubicin - analogs & derivatives | Angiogenesis Inhibitors - therapeutic use | Antimetabolites, Antineoplastic - pharmacology | Female | Quinazolines - administration & dosage | Antineoplastic Agents - pharmacology | Paclitaxel - administration & dosage | Everolimus | Ovarian Neoplasms - drug therapy | Recombinant Fusion Proteins - administration & dosage | Doxorubicin - administration & dosage | Sirolimus - analogs & derivatives | Folic Acid - analogs & derivatives | Phthalazines - administration & dosage | Pyrimidines - administration & dosage | Deoxycytidine - administration & dosage | Angiogenesis Inhibitors - pharmacology | Carboplatin - administration & dosage | Poly(ADP-ribose) Polymerase Inhibitors | Polyethylene Glycols - administration & dosage | Sirolimus - administration & dosage | Antimetabolites, Antineoplastic - therapeutic use | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Nivolumab | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Topotecan - administration & dosage | Deoxycytidine - analogs & derivatives | Sulfonamides - administration & dosage
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 13, pp. 1306 - 1315
Summary Background In the TRIBE study, FOLFOXIRI (fluorouracil, leucovorin, oxaliplatin, and irinotecan) plus bevacizumab significantly improved... 
Hematology, Oncology and Palliative Medicine | TRIAL | CETUXIMAB | SURROGATE | LEUCOVORIN | ONCOLOGY | END-POINT | PROGRESSION-FREE SURVIVAL | RAS MUTATIONS | GUIDELINES | KRAS | FLUOROURACIL | Leucovorin - administration & dosage | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Bevacizumab - therapeutic use | Bevacizumab - adverse effects | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Angiogenesis Inhibitors - administration & dosage | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Time Factors | DNA Mutational Analysis | Colorectal Neoplasms - drug therapy | Angiogenesis Inhibitors - therapeutic use | Camptothecin - administration & dosage | Female | Angiogenesis Inhibitors - adverse effects | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Bevacizumab - administration & dosage | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Proto-Oncogene Proteins - genetics | Treatment Outcome | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Intention to Treat Analysis | Italy | Aged | Infusions, Intravenous | Mutation | Colorectal Neoplasms - pathology | Antimitotic agents | Cancer patients | Care and treatment | Patient outcomes | Analysis | Colorectal cancer | Leucovorin | Metastasis | Antineoplastic agents
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 5, pp. 499 - 508
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 387, Issue 10032, pp. 2008 - 2016
Journal Article
Journal Article
The lancet oncology, ISSN 1470-2045, 2013, Volume 14, Issue 13, pp. 1278 - 1286
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2014, Volume 32, Issue 13, pp. 1302 - 1308
Journal Article
Journal Article
The lancet oncology, ISSN 1470-2045, 2017, Volume 18, Issue 10, pp. 1360 - 1372
Journal Article